| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 4.67e-13 | 35 | 73 | 8 | GO:0015020 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PRLHR ADRA1D GPR21 GPR65 P2RY12 ADGRG2 CXCR6 PTPRR GPR35 GLP1R UNC5C SCN7A S1PR2 LPAR2 CCR7 TAS2R40 TNFRSF10B IL1R1 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 2.29e-10 | 1353 | 73 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.84e-10 | 28 | 73 | 6 | GO:0001972 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | PRLHR ADRA1D GPR21 GPR65 P2RY12 ADGRG2 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 1.98e-09 | 884 | 73 | 18 | GO:0004930 |
| GeneOntologyMolecularFunction | retinoid binding | 2.10e-08 | 48 | 73 | 6 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.39e-08 | 49 | 73 | 6 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A4 UGT1A3 UGT1A5 DPY19L4 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 7.49e-08 | 211 | 73 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 8.72e-08 | 153 | 73 | 8 | GO:0008194 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 2.89e-07 | 16 | 73 | 4 | GO:0045125 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A4 UGT1A3 UGT1A5 DPY19L4 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 1.03e-06 | 288 | 73 | 9 | GO:0016757 |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.58e-06 | 239 | 73 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.61e-06 | 107 | 73 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.04e-06 | 254 | 73 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 1.15e-04 | 26 | 73 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.15e-04 | 26 | 73 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 1.15e-04 | 26 | 73 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 1.31e-04 | 5 | 73 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | lipid binding | UGT1A4 UGT1A3 GPR155 UGT1A5 NPC1L1 UGT2B4 UGT2B7 UGT2B15 S1PR2 LPAR2 S1PR1 LPAR1 | 2.27e-04 | 988 | 73 | 12 | GO:0008289 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.91e-04 | 465 | 73 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 3.64e-04 | 8 | 73 | 2 | GO:0038036 | |
| GeneOntologyMolecularFunction | C-X-C chemokine receptor activity | 3.64e-04 | 8 | 73 | 2 | GO:0016494 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.08e-04 | 171 | 73 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 4.41e-04 | 97 | 73 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | sodium channel activity | 9.11e-04 | 52 | 73 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.07e-03 | 123 | 73 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.44e-03 | 133 | 73 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.73e-03 | 758 | 73 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.73e-03 | 140 | 73 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.02e-03 | 627 | 73 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | transporter activity | SCN11A SLC9A8 SLC4A7 KCNA10 CFTR NPC1L1 SCN7A SCN9A ATP11C KCNMB4 ATP2B2 SLC35A5 | 2.34e-03 | 1289 | 73 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.34e-03 | 793 | 73 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.87e-03 | 664 | 73 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | immune receptor activity | 3.14e-03 | 165 | 73 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 3.17e-03 | 23 | 73 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 3.45e-03 | 24 | 73 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | protease binding | 4.37e-03 | 181 | 73 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 6.09e-03 | 32 | 73 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | chemokine binding | 6.47e-03 | 33 | 73 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.47e-03 | 33 | 73 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.64e-03 | 459 | 73 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 8.08e-03 | 37 | 73 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.41e-03 | 343 | 73 | 5 | GO:0005261 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.25e-15 | 21 | 73 | 8 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.46e-14 | 26 | 73 | 8 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.46e-14 | 26 | 73 | 8 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.45e-12 | 12 | 73 | 6 | GO:0052697 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.68e-11 | 8 | 73 | 5 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.20e-10 | 10 | 73 | 5 | GO:0018879 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | ADRA1D GPR65 ADGRG2 GLP1R S1PR2 LPAR2 S1PR1 LPAR1 ADCY5 OPRD1 | 1.37e-09 | 191 | 73 | 10 | GO:0007189 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ADRA1D GPR65 P2RY12 ADGRG2 GLP1R S1PR2 LPAR2 S1PR1 LPAR1 ADCY5 OPRD1 | 4.99e-09 | 286 | 73 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.85e-08 | 52 | 73 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | SCN11A PRLHR ADRA1D GPR21 GPR65 P2RY12 ADGRG2 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 ADCY5 OR14A16 OPRD1 | 4.73e-08 | 1395 | 73 | 20 | GO:0007186 |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.93e-07 | 37 | 73 | 5 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.93e-07 | 37 | 73 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 2.21e-07 | 38 | 73 | 5 | GO:0008209 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.25e-06 | 224 | 73 | 8 | GO:0007204 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A TMEM163 KCNMB4 CCR7 ATP2B2 OPRD1 | 1.79e-06 | 1000 | 73 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A TMEM163 KCNMB4 CCR7 ATP2B2 | 3.64e-06 | 922 | 73 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A TMEM163 KCNMB4 CCR7 ATP2B2 | 4.66e-06 | 942 | 73 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A ATP11C TMEM163 KCNMB4 CCR7 ATP2B2 | 6.77e-06 | 1115 | 73 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A4 UGT1A3 CFTR NPC1L1 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 7.01e-06 | 376 | 73 | 9 | GO:0008202 |
| GeneOntologyBiologicalProcess | hormone metabolic process | 7.63e-06 | 286 | 73 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 7.67e-06 | 133 | 73 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A TMEM163 KCNMB4 CCR7 ATP2B2 OPRD1 | 1.05e-05 | 1157 | 73 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.07e-05 | 141 | 73 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A TMEM163 KCNMB4 CCR7 ATP2B2 | 1.11e-05 | 1017 | 73 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 1.32e-05 | 41 | 73 | 4 | GO:0035025 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.35e-05 | 86 | 73 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A SLC9A8 SLC4A7 KCNA10 P2RY12 GPR35 GLP1R CFTR SCN7A SCN9A ATP11C TMEM163 KCNMB4 CCR7 ATP2B2 OPRD1 | 1.94e-05 | 1374 | 73 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | UGT1A3 PRLHR GLP1R FURIN CFTR UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 ADCY5 | 2.70e-05 | 684 | 73 | 11 | GO:0010817 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.83e-05 | 112 | 73 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 7.34e-05 | 63 | 73 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | action potential | 7.86e-05 | 201 | 73 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.49e-05 | 208 | 73 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 1.23e-04 | 5 | 73 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 1.23e-04 | 5 | 73 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.36e-04 | 222 | 73 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.54e-04 | 559 | 73 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 3.19e-04 | 92 | 73 | 4 | GO:0051057 | |
| GeneOntologyBiologicalProcess | regulation of Rho protein signal transduction | 4.06e-04 | 98 | 73 | 4 | GO:0035023 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.29e-04 | 275 | 73 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 4.38e-04 | 9 | 73 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | chemotaxis | 4.75e-04 | 517 | 73 | 8 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 4.88e-04 | 519 | 73 | 8 | GO:0042330 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 5.26e-04 | 525 | 73 | 8 | GO:0009410 | |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 5.46e-04 | 10 | 73 | 2 | GO:0045759 | |
| GeneOntologyBiologicalProcess | heart contraction | 6.54e-04 | 298 | 73 | 6 | GO:0060047 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 7.84e-04 | 51 | 73 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | heart process | 7.90e-04 | 309 | 73 | 6 | GO:0003015 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic receptor signaling pathway | 9.40e-04 | 13 | 73 | 2 | GO:0035588 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating dopamine receptor signaling pathway | 9.40e-04 | 13 | 73 | 2 | GO:0007191 | |
| GeneOntologyBiologicalProcess | G protein-coupled adenosine receptor signaling pathway | 9.40e-04 | 13 | 73 | 2 | GO:0001973 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 EIF2AK3 | 1.07e-03 | 731 | 73 | 9 | GO:0032787 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.09e-03 | 57 | 73 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | sphingosine-1-phosphate receptor signaling pathway | 1.26e-03 | 15 | 73 | 2 | GO:0003376 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.38e-03 | 62 | 73 | 3 | GO:0086002 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.70e-07 | 40 | 73 | 5 | GO:0005640 | |
| GeneOntologyCellularComponent | cell surface | P2RY12 ADGRG2 CXCR6 SIGLEC9 FURIN CFTR UNC5C LPAR2 CCR7 TNFRSF10B IL1R1 S1PR1 LPAR1 CLEC2B | 2.58e-05 | 1111 | 73 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.68e-05 | 17 | 73 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | nuclear membrane | TMEM176B SHISA5 DPY19L4 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 2.91e-05 | 349 | 73 | 8 | GO:0031965 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UGT1A4 UGT1A3 SHISA5 UGT1A5 FURIN CFTR VPS13A UGT2B4 UGT2B7 UGT2B15 ATP11C UGT2B28 UGT2B11 RNF139 EIF2AK3 | 3.33e-05 | 1293 | 73 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UGT1A4 UGT1A3 SHISA5 UGT1A5 FURIN CFTR VPS13A UGT2B4 UGT2B7 UGT2B15 ATP11C UGT2B28 UGT2B11 RNF139 EIF2AK3 | 3.51e-05 | 1299 | 73 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UGT1A4 UGT1A3 SHISA5 UGT1A5 FURIN CFTR VPS13A UGT2B4 UGT2B7 UGT2B15 ATP11C UGT2B28 UGT2B11 RNF139 EIF2AK3 | 4.49e-05 | 1327 | 73 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | sodium channel complex | 1.40e-04 | 29 | 73 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | organelle outer membrane | 4.31e-04 | 279 | 73 | 6 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 4.48e-04 | 281 | 73 | 6 | GO:0019867 | |
| GeneOntologyCellularComponent | nuclear envelope | TMEM176B SHISA5 DPY19L4 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 7.35e-04 | 560 | 73 | 8 | GO:0005635 |
| GeneOntologyCellularComponent | lysosomal membrane | 1.14e-03 | 462 | 73 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.14e-03 | 462 | 73 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | cation channel complex | 1.39e-03 | 235 | 73 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.94e-03 | 507 | 73 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.06e-03 | 378 | 73 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.21e-03 | 519 | 73 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.84e-03 | 277 | 73 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | transporter complex | 3.06e-03 | 550 | 73 | 7 | GO:1990351 | |
| Domain | UDPGT | 5.68e-15 | 21 | 71 | 8 | PS00375 | |
| Domain | UDPGT | 5.68e-15 | 21 | 71 | 8 | PF00201 | |
| Domain | UDP_glucos_trans | 5.68e-15 | 21 | 71 | 8 | IPR002213 | |
| Domain | GPCR_Rhodpsn_7TM | PRLHR ADRA1D GPR21 GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 2.54e-08 | 670 | 71 | 15 | IPR017452 |
| Domain | 7tm_1 | PRLHR ADRA1D GPR21 GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 2.92e-08 | 677 | 71 | 15 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | PRLHR ADRA1D GPR21 GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 3.40e-08 | 685 | 71 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | PRLHR ADRA1D GPR21 GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 3.82e-08 | 691 | 71 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | PRLHR ADRA1D GPR21 GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OR14A16 OPRD1 | 3.89e-08 | 692 | 71 | 15 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | 2.24e-07 | 112 | 71 | 7 | SM01381 | |
| Domain | Na_channel_asu | 6.20e-06 | 10 | 71 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 6.20e-06 | 10 | 71 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 6.20e-06 | 10 | 71 | 3 | PF06512 | |
| Domain | LPA_rcpt_EDG2 | 1.42e-05 | 2 | 71 | 2 | IPR002277 | |
| Domain | LPA_rcpt | 4.26e-05 | 3 | 71 | 2 | IPR004065 | |
| Domain | Channel_four-helix_dom | 6.50e-05 | 57 | 71 | 4 | IPR027359 | |
| Domain | - | 6.50e-05 | 57 | 71 | 4 | 1.20.120.350 | |
| Domain | S1P_rcpt | 1.41e-04 | 5 | 71 | 2 | IPR004061 | |
| Domain | Ion_trans_dom | 9.34e-04 | 114 | 71 | 4 | IPR005821 | |
| Domain | Ion_trans | 9.34e-04 | 114 | 71 | 4 | PF00520 | |
| Domain | Chemokine_rcpt | 1.65e-03 | 16 | 71 | 2 | IPR000355 | |
| Domain | DEATH | 4.70e-03 | 27 | 71 | 2 | SM00005 | |
| Domain | - | 6.57e-03 | 32 | 71 | 2 | 2.70.150.10 | |
| Domain | - | 6.57e-03 | 32 | 71 | 2 | 3.40.1110.10 | |
| Domain | Death | 6.97e-03 | 33 | 71 | 2 | PF00531 | |
| Domain | GPCR_2_secretin-like_CS | 7.39e-03 | 34 | 71 | 2 | IPR017983 | |
| Domain | ATPase_P-typ_cyto_domN | 7.82e-03 | 35 | 71 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 8.26e-03 | 36 | 71 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 8.26e-03 | 36 | 71 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.26e-03 | 36 | 71 | 2 | PS00154 | |
| Domain | Cadherin_tail | 8.71e-03 | 37 | 71 | 2 | PF15974 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.71e-03 | 37 | 71 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.71e-03 | 37 | 71 | 2 | PF00122 | |
| Domain | Cadherin_CBD | 8.71e-03 | 37 | 71 | 2 | IPR031904 | |
| Domain | Death_domain | 9.17e-03 | 38 | 71 | 2 | IPR000488 | |
| Domain | DEATH_DOMAIN | 9.17e-03 | 38 | 71 | 2 | PS50017 | |
| Domain | Cadherin_C_2 | 1.11e-02 | 42 | 71 | 2 | PF16492 | |
| Domain | Cadherin_C | 1.11e-02 | 42 | 71 | 2 | IPR032455 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.32e-14 | 23 | 58 | 8 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.47e-14 | 24 | 58 | 8 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.09e-14 | 25 | 58 | 8 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 5.09e-14 | 25 | 58 | 8 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.09e-14 | 25 | 58 | 8 | M605 | |
| Pathway | WP_GLUCURONIDATION | 7.33e-14 | 26 | 58 | 8 | M39404 | |
| Pathway | WP_GPCRS_NONODORANT | PRLHR ADRA1D GPR65 P2RY12 ADGRG2 CXCR6 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 OPRD1 | 1.33e-13 | 266 | 58 | 15 | MM15843 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.45e-13 | 28 | 58 | 8 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.27e-12 | 41 | 58 | 8 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.85e-12 | 44 | 58 | 8 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.52e-12 | 45 | 58 | 8 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.76e-11 | 51 | 58 | 8 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.25e-11 | 52 | 58 | 8 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.21e-11 | 55 | 58 | 8 | M14933 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 OPRD1 | 1.29e-10 | 430 | 58 | 15 | MM15160 |
| Pathway | KEGG_RETINOL_METABOLISM | 1.84e-10 | 64 | 58 | 8 | M9488 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 OPRD1 | 3.63e-10 | 463 | 58 | 15 | M507 |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.85e-10 | 70 | 58 | 8 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.85e-10 | 72 | 58 | 8 | M9257 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OPRD1 | 6.13e-10 | 330 | 58 | 13 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 S1PR2 LPAR2 CCR7 S1PR1 GPR132 LPAR1 OPRD1 | 6.84e-10 | 333 | 58 | 13 | MM14963 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 ADCY5 OPRD1 | 4.17e-09 | 646 | 58 | 16 | MM14962 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.18e-08 | 107 | 58 | 8 | MM14595 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PRLHR ADRA1D GPR65 P2RY12 CXCR6 GPR35 GLP1R S1PR2 LPAR2 CCR7 TAS2R40 S1PR1 GPR132 LPAR1 ADCY5 OPRD1 | 1.36e-08 | 702 | 58 | 16 | M746 |
| Pathway | REACTOME_DRUG_ADME | 1.37e-08 | 109 | 58 | 8 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.37e-08 | 109 | 58 | 8 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 2.74e-08 | 119 | 58 | 8 | MM15692 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.50e-07 | 14 | 58 | 4 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.50e-07 | 14 | 58 | 4 | MM15062 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.11e-07 | 39 | 58 | 5 | MM15695 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.62e-07 | 183 | 58 | 8 | M39588 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.51e-06 | 272 | 58 | 9 | M13380 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.49e-06 | 289 | 58 | 9 | MM15057 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.93e-06 | 219 | 58 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.04e-06 | 220 | 58 | 8 | M10320 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.91e-06 | 314 | 58 | 9 | M600 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.04e-05 | 260 | 58 | 8 | M39397 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.90e-05 | 15 | 58 | 3 | MM15697 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 5.16e-05 | 18 | 58 | 3 | MM15858 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 6.11e-05 | 19 | 58 | 3 | M39728 | |
| Pathway | REACTOME_HEME_DEGRADATION | 7.17e-05 | 20 | 58 | 3 | MM14721 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 8.34e-05 | 21 | 58 | 3 | M39631 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.74e-04 | 31 | 58 | 3 | M877 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 3.01e-04 | 32 | 58 | 3 | MM14719 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.01e-04 | 32 | 58 | 3 | M27455 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 5.88e-04 | 9 | 58 | 2 | MM1477 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 5.88e-04 | 9 | 58 | 2 | M47732 | |
| Pathway | WP_GPCRS_OTHER | 6.47e-04 | 96 | 58 | 4 | MM15939 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.33e-04 | 10 | 58 | 2 | M46430 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M17668 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 9.86e-04 | 186 | 58 | 5 | MM15994 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 1.26e-03 | 13 | 58 | 2 | M47731 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.47e-03 | 14 | 58 | 2 | M39328 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.69e-03 | 210 | 58 | 5 | MM15043 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.92e-03 | 16 | 58 | 2 | M39849 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.95e-03 | 217 | 58 | 5 | M18437 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.99e-03 | 130 | 58 | 4 | M27454 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 2.41e-03 | 65 | 58 | 3 | M15 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 2.44e-03 | 18 | 58 | 2 | M39424 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.98e-03 | 70 | 58 | 3 | MM15959 | |
| Pathway | PID_S1P_META_PATHWAY | 3.32e-03 | 21 | 58 | 2 | M155 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.62e-03 | 75 | 58 | 3 | M39696 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.65e-03 | 22 | 58 | 2 | MM15888 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 3.98e-03 | 23 | 58 | 2 | M47549 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 3.98e-03 | 23 | 58 | 2 | MM15952 | |
| Pathway | WP_UNFOLDED_PROTEIN_RESPONSE | 4.33e-03 | 24 | 58 | 2 | M39878 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 4.33e-03 | 24 | 58 | 2 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 4.33e-03 | 24 | 58 | 2 | MM15992 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 4.70e-03 | 25 | 58 | 2 | M39384 | |
| Pubmed | 7.42e-13 | 7 | 73 | 5 | 26074487 | ||
| Pubmed | 1.32e-12 | 66 | 73 | 8 | 19898482 | ||
| Pubmed | 1.97e-12 | 8 | 73 | 5 | 32093886 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.77e-11 | 12 | 73 | 5 | 20308471 | |
| Pubmed | 2.77e-11 | 12 | 73 | 5 | 18161889 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.24e-09 | 8 | 73 | 4 | 12695355 | |
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 22579593 | ||
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 10748067 | ||
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 18719240 | ||
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 20142249 | ||
| Pubmed | 3.71e-09 | 10 | 73 | 4 | 12401212 | ||
| Pubmed | 3.71e-09 | 10 | 73 | 4 | 16434032 | ||
| Pubmed | 4.25e-09 | 179 | 73 | 8 | 18577758 | ||
| Pubmed | Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. | 5.83e-09 | 11 | 73 | 4 | 20458606 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 7835904 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 27098059 | ||
| Pubmed | Expression patterns of the lysophospholipid receptor genes during mouse early development. | 1.26e-08 | 13 | 73 | 4 | 18924241 | |
| Pubmed | 1.76e-08 | 14 | 73 | 4 | 9295054 | ||
| Pubmed | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. | 2.40e-08 | 15 | 73 | 4 | 24602016 | |
| Pubmed | Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. | 3.54e-08 | 4 | 73 | 3 | 10818441 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 9931453 | ||
| Pubmed | Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. | 3.54e-08 | 4 | 73 | 3 | 11087877 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 26176234 | ||
| Pubmed | 5.34e-08 | 18 | 73 | 4 | 20056724 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 15318931 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 11443127 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 19293149 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 18052087 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 22511988 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 1339448 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 23642732 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 11465080 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.05e-06 | 10 | 73 | 3 | 22558097 | |
| Pubmed | 1.54e-06 | 40 | 73 | 4 | 21319224 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 1.77e-06 | 95 | 73 | 5 | 16754659 | |
| Pubmed | 1.93e-06 | 12 | 73 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.93e-06 | 12 | 73 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.50e-06 | 13 | 73 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.50e-06 | 13 | 73 | 3 | 25246029 | |
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.18e-06 | 14 | 73 | 3 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 3.18e-06 | 14 | 73 | 3 | 14672974 | |
| Pubmed | 4.14e-06 | 200 | 73 | 6 | 18240029 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25673082 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 14871856 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10222050 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 8068691 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18754873 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16631609 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 27795544 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24641623 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28962835 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 39171428 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34502385 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17687269 | ||
| Pubmed | Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. | 4.35e-06 | 2 | 73 | 2 | 14625558 | |
| Pubmed | Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. | 4.35e-06 | 2 | 73 | 2 | 18836069 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17263731 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11144347 | ||
| Pubmed | Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. | 4.35e-06 | 2 | 73 | 2 | 15195086 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26303110 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25557733 | ||
| Pubmed | Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. | 4.35e-06 | 2 | 73 | 2 | 18323526 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21679149 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33427061 | ||
| Pubmed | Cell type-specific localization of human cardiac S1P receptors. | 4.35e-06 | 2 | 73 | 2 | 11967277 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26327335 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23300082 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 37340142 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17496233 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15319348 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35136060 | ||
| Pubmed | Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels. | 4.35e-06 | 2 | 73 | 2 | 32601768 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 9804623 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18164221 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18703779 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24367540 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 14570768 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12215548 | ||
| Pubmed | Modulation of LPA receptor expression in the human brain following neurotrauma. | 4.35e-06 | 2 | 73 | 2 | 21234797 | |
| Pubmed | Lysophosphatidic acid signaling may initiate fetal hydrocephalus. | 4.35e-06 | 2 | 73 | 2 | 21900594 | |
| Pubmed | UGT polymorphisms and lamotrigine clearance during pregnancy. | 4.35e-06 | 2 | 73 | 2 | 29395496 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 4.87e-06 | 16 | 73 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 5.91e-06 | 17 | 73 | 3 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 8.39e-06 | 19 | 73 | 3 | 23281178 | |
| Pubmed | Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma. | 1.30e-05 | 3 | 73 | 2 | 30712233 | |
| Pubmed | A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. | 1.30e-05 | 3 | 73 | 2 | 23148237 | |
| Pubmed | Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. | 1.30e-05 | 3 | 73 | 2 | 22015657 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 35333897 | ||
| Pubmed | Differential expression of sphingosine-1-phosphate receptors in abdominal aortic aneurysms. | 1.30e-05 | 3 | 73 | 2 | 22547907 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25661196 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19572376 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21659540 | ||
| Pubmed | Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection. | 1.30e-05 | 3 | 73 | 2 | 25500839 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26282174 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15208267 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 24613836 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16504475 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11915348 | ||
| Interaction | CERS6 interactions | 1.94e-09 | 104 | 67 | 8 | int:CERS6 | |
| Interaction | SLC15A4 interactions | 3.89e-08 | 29 | 67 | 5 | int:SLC15A4 | |
| Interaction | KIAA2013 interactions | 1.14e-07 | 116 | 67 | 7 | int:KIAA2013 | |
| Interaction | SACM1L interactions | 7.20e-07 | 152 | 67 | 7 | int:SACM1L | |
| Interaction | TTYH3 interactions | 5.03e-06 | 75 | 67 | 5 | int:TTYH3 | |
| Interaction | ACP2 interactions | 8.29e-06 | 83 | 67 | 5 | int:ACP2 | |
| Interaction | SLC30A7 interactions | 9.32e-06 | 85 | 67 | 5 | int:SLC30A7 | |
| Interaction | PTDSS2 interactions | 1.17e-05 | 89 | 67 | 5 | int:PTDSS2 | |
| Interaction | CMTM6 interactions | 1.17e-05 | 89 | 67 | 5 | int:CMTM6 | |
| Interaction | ITM2C interactions | 1.96e-05 | 99 | 67 | 5 | int:ITM2C | |
| Interaction | TSPAN3 interactions | 2.16e-05 | 101 | 67 | 5 | int:TSPAN3 | |
| Interaction | ATP2C1 interactions | 2.16e-05 | 101 | 67 | 5 | int:ATP2C1 | |
| Interaction | XPO4 interactions | 2.27e-05 | 102 | 67 | 5 | int:XPO4 | |
| Interaction | TSPAN15 interactions | 3.61e-05 | 276 | 67 | 7 | int:TSPAN15 | |
| Interaction | MFSD8 interactions | 4.42e-05 | 59 | 67 | 4 | int:MFSD8 | |
| Interaction | GPR89A interactions | 4.95e-05 | 120 | 67 | 5 | int:GPR89A | |
| Interaction | TMBIM6 interactions | 5.15e-05 | 121 | 67 | 5 | int:TMBIM6 | |
| Interaction | UGT1A3 interactions | 1.08e-04 | 5 | 67 | 2 | int:UGT1A3 | |
| Interaction | TM9SF3 interactions | 1.14e-04 | 143 | 67 | 5 | int:TM9SF3 | |
| Interaction | ATP2A3 interactions | 1.21e-04 | 232 | 67 | 6 | int:ATP2A3 | |
| Interaction | NDUFAF1 interactions | 1.25e-04 | 146 | 67 | 5 | int:NDUFAF1 | |
| Interaction | LMBR1 interactions | 1.32e-04 | 78 | 67 | 4 | int:LMBR1 | |
| Interaction | TNPO3 interactions | 1.36e-04 | 237 | 67 | 6 | int:TNPO3 | |
| Interaction | UGT2B28 interactions | 1.62e-04 | 6 | 67 | 2 | int:UGT2B28 | |
| Interaction | GINM1 interactions | 1.76e-04 | 84 | 67 | 4 | int:GINM1 | |
| Interaction | SORCS1 interactions | 2.26e-04 | 7 | 67 | 2 | int:SORCS1 | |
| Interaction | UGT2B11 interactions | 2.26e-04 | 7 | 67 | 2 | int:UGT2B11 | |
| Interaction | ATP9A interactions | 2.30e-04 | 90 | 67 | 4 | int:ATP9A | |
| Interaction | FAM241B interactions | 2.30e-04 | 90 | 67 | 4 | int:FAM241B | |
| Interaction | TMEM164 interactions | 2.52e-04 | 37 | 67 | 3 | int:TMEM164 | |
| Interaction | GNAI1 interactions | 2.62e-04 | 171 | 67 | 5 | int:GNAI1 | |
| Interaction | XKR8 interactions | 3.01e-04 | 8 | 67 | 2 | int:XKR8 | |
| Interaction | ITPRIPL1 interactions | 3.18e-04 | 40 | 67 | 3 | int:ITPRIPL1 | |
| Interaction | RPRM interactions | 3.19e-04 | 98 | 67 | 4 | int:RPRM | |
| Interaction | DGAT1 interactions | 3.42e-04 | 41 | 67 | 3 | int:DGAT1 | |
| Interaction | SMAGP interactions | 3.67e-04 | 42 | 67 | 3 | int:SMAGP | |
| Interaction | TNFRSF10C interactions | 3.85e-04 | 103 | 67 | 4 | int:TNFRSF10C | |
| Interaction | PAQR6 interactions | 3.86e-04 | 9 | 67 | 2 | int:PAQR6 | |
| Interaction | SAAL1 interactions | 3.95e-04 | 187 | 67 | 5 | int:SAAL1 | |
| Interaction | HTR3A interactions | 4.61e-04 | 108 | 67 | 4 | int:HTR3A | |
| Interaction | TTYH1 interactions | 4.82e-04 | 300 | 67 | 6 | int:TTYH1 | |
| Interaction | EXTL2 interactions | 5.13e-04 | 47 | 67 | 3 | int:EXTL2 | |
| Interaction | ALG10 interactions | 5.80e-04 | 49 | 67 | 3 | int:ALG10 | |
| Cytoband | 4q13 | 1.73e-06 | 15 | 73 | 3 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 5.46e-06 | 157 | 73 | 5 | chr4q13 | |
| Cytoband | 2q37 | 1.68e-05 | 31 | 73 | 3 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 4.77e-04 | 226 | 73 | 4 | chr2q37 | |
| Cytoband | 4q13.2 | 1.13e-03 | 31 | 73 | 2 | 4q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q15 | 3.63e-03 | 56 | 73 | 2 | chr12q15 | |
| GeneFamily | UDP glucuronosyltransferases | 4.99e-14 | 32 | 56 | 8 | 363 | |
| GeneFamily | Sphingosine 1-phosphate receptors|CD molecules | 9.37e-05 | 5 | 56 | 2 | 206 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.93e-05 | 78 | 56 | 4 | 262 | |
| GeneFamily | Lysophosphatidic acid receptors | 1.40e-04 | 6 | 56 | 2 | 205 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.05e-04 | 394 | 56 | 7 | 471 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.35e-04 | 9 | 56 | 2 | 1203 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 4.03e-07 | 103 | 72 | 6 | MM919 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.04e-06 | 121 | 72 | 6 | MM935 | |
| Coexpression | GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN | 8.82e-06 | 175 | 72 | 6 | M7101 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.38e-05 | 53 | 72 | 4 | MM1203 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.41e-05 | 190 | 72 | 6 | MM1311 | |
| Coexpression | HALLMARK_INFLAMMATORY_RESPONSE | 1.88e-05 | 200 | 72 | 6 | M5932 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 170 | 73 | 7 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-08 | 172 | 73 | 7 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-08 | 176 | 73 | 7 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-07 | 167 | 73 | 6 | 10c9fab3573c2948081aac2cec1798e46e59e38a | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-07 | 169 | 73 | 6 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 3.55e-07 | 169 | 73 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 171 | 73 | 6 | f08402d0f42822c35673522043b652f8fb68d2f6 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-07 | 172 | 73 | 6 | d098e8a9c7666354803225cf2650faad436bab66 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-07 | 173 | 73 | 6 | da0f1461643294f92e20b5e456a50211a2780a91 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 4.07e-07 | 173 | 73 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-07 | 174 | 73 | 6 | 319bfafc66a21ad05ab35e0fd024c8b372a07165 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-07 | 175 | 73 | 6 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-07 | 175 | 73 | 6 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-07 | 175 | 73 | 6 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-07 | 177 | 73 | 6 | 9d2d70d53b919fed3328812889a55e5e1a0759de | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-07 | 177 | 73 | 6 | 9828504591599619649d41a78daf7c052729c669 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-07 | 180 | 73 | 6 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 5.31e-07 | 181 | 73 | 6 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 183 | 73 | 6 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 183 | 73 | 6 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-07 | 187 | 73 | 6 | fae08f34dc4b15352bd4d10bc6c924fe119b5d5e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | 890e80d0ee3cd548e4c1d0fa917c1d4080a06c13 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | 67dc43f17f4b75c6a841bca5e2755fa895b390ab | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-07 | 187 | 73 | 6 | e6b140b9fb582abf07aa6ea9bc437de3ba0d6de1 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 6.63e-07 | 188 | 73 | 6 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-07 | 188 | 73 | 6 | 13e72b0a2b62d95c805294645fca79d8f96e9e78 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.71e-07 | 197 | 73 | 6 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 73 | 6 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.51e-07 | 200 | 73 | 6 | 482dfbbd8958b64c31568dccbffe3cc9589f876b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.22e-06 | 128 | 73 | 5 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.22e-06 | 128 | 73 | 5 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-06 | 131 | 73 | 5 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.67e-06 | 149 | 73 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.67e-06 | 149 | 73 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 5.31e-06 | 153 | 73 | 5 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-06 | 153 | 73 | 5 | 0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-06 | 155 | 73 | 5 | 0e24e767a3895d31d34cabeaca0354aadae34e44 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-06 | 155 | 73 | 5 | f3489a548a2c0cc2d9117ff85865c6089ea0835d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 156 | 73 | 5 | 39aa3adbee9f04cdc0055487d393edfa515e062b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 156 | 73 | 5 | a09e3aefe78d63ad5428ad48c6f83e547eb819f6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 158 | 73 | 5 | b1b1e50ddd231dcd10cc8e6bb68b2a5e0bb1450a | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 6.40e-06 | 159 | 73 | 5 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 160 | 73 | 5 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | Immune_cells-T_cells|World / Lineage and Cell class | 7.22e-06 | 163 | 73 | 5 | c5afdb5e7700bbd3ee8276910f9c4b4b3bcc3266 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-06 | 163 | 73 | 5 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.44e-06 | 164 | 73 | 5 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 7.67e-06 | 165 | 73 | 5 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | droplet-Bladder-Unstain-18m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 166 | 73 | 5 | 00c53ee34ff4b988a9accd296bc0a2e14d9e7c49 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-06 | 167 | 73 | 5 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.37e-06 | 168 | 73 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 168 | 73 | 5 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 168 | 73 | 5 | dc1143bd8db70c490167d73a525fd9b783eba960 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-06 | 168 | 73 | 5 | a75d63ae8ad64b5560853775f6df398feb314ce8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.61e-06 | 169 | 73 | 5 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.61e-06 | 169 | 73 | 5 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-06 | 170 | 73 | 5 | c4f00c1acde1d3b521101e469101d10fd257653e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-06 | 170 | 73 | 5 | 7040f7b1e4d8d26db787449e557371c5d872c95a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-06 | 170 | 73 | 5 | d3c1edaf0190d8927578043c372dba7477e75e14 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 171 | 73 | 5 | e2b72282244dee008e3b5d03667be9f26b7c2f6d | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 171 | 73 | 5 | 1064c20c37fae6cefb2eb4fa0628e4037a78179c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.38e-06 | 172 | 73 | 5 | 09c03cc7717373f10e51281be76d53979fcb7ccd | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.64e-06 | 173 | 73 | 5 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 173 | 73 | 5 | 97391a763c17ce0107c9e2386e88c417ac75a72e | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.64e-06 | 173 | 73 | 5 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | facs-Marrow-T-cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 173 | 73 | 5 | 806f94f5c3ac836ddffc389d3c2cd7e4da7a608d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 73 | 5 | b66731573e79576fbf17538059cb8243dd4903c4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 73 | 5 | 5f18077e5c3edc6a2708315db53683afa4a6d4a8 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 73 | 5 | 2cd85b619f0d4771064db34959f154de3a40f15b | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 73 | 5 | 5d9b1d398c1caead7538f19ce1ae207d3e127bfd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 73 | 5 | ca2eabf03b70353e7eb15b6f622b2f9223a99e18 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 176 | 73 | 5 | 27c5ddd67de52101360ef7de8fcfa041066d97db | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 177 | 73 | 5 | 872f05dca01e6d89a0b69d1a34840f09a2fa1948 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 177 | 73 | 5 | 76be975de7ebb2f8f7ea642244757a6dd44acd72 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 178 | 73 | 5 | 7c101e3957ea9b0d4ebf619d1d02e7e64ae28915 | |
| ToppCell | Immune_cells-T_cells|Immune_cells / Lineage and Cell class | 1.11e-05 | 178 | 73 | 5 | af420242277e2a4e2524002a2914b0538f79a134 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | eadcb22045f66b37ca7ec041dd314cafa50b1911 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | 8bf04a7ad1b0be6722ebfdceba3f083f07bf96c5 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | 556f8e67475a6ece6acbe6f274b2451049000384 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | 86cdb1652f1736c38b501f07cf40ce99134cf597 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | f3f7a610db750fcb84d746a5ea0d8b57f9b7d901 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | 115ce9f048f933704a19759948dcc933245e63c4 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 73 | 5 | bb2f1b254371924b2045e9e1a81b6dbf4f00dd6a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 181 | 73 | 5 | 923b369b1404103f124fcbffa866de26f9d68d33 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-05 | 181 | 73 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 181 | 73 | 5 | 7fd96238673c9596562c43e7c5ddbab7d0e6c0c6 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 182 | 73 | 5 | 0fbc70527059cab8be16ae7348c791dfff159604 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 182 | 73 | 5 | 4d27bd13d5507862e8cca5def655f93b5c919a0e | |
| ToppCell | facs-Trachea-24m-Hematologic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 182 | 73 | 5 | a6162498a8a41a7fdf84d744e4203f99dfb284fa | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 183 | 73 | 5 | 27219ad7ecdeeb9e55e39772992e14f6c497d020 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.27e-05 | 183 | 73 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 183 | 73 | 5 | f7852779190e3ea835d0eedd415870d9fd789bc2 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-05 | 185 | 73 | 5 | 7e3d9f5050e71e91021245c11101e994ae41d22b | |
| ToppCell | droplet-Mammary_Gland-nan-3m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | 02a2cbae9238c6c1e80b9a52a575e3b22f0eebb4 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | a3b937163346d729115e6335336e33d3e71fccb0 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 186 | 73 | 5 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.37e-05 | 186 | 73 | 5 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 73 | 5 | 1154a42d0fe18859dc289222a4ef39d1d742d4b4 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 73 | 5 | 3e16781b9646de971d953da2c49d4210a4c23fe3 | |
| Computational | Genes in the cancer module 227. | 2.27e-05 | 15 | 41 | 3 | MODULE_227 | |
| Computational | Steroid hormone and heme metabolism. | 2.79e-05 | 16 | 41 | 3 | MODULE_505 | |
| Computational | Neighborhood of CD97 | 3.96e-04 | 38 | 41 | 3 | GNF2_CD97 | |
| Computational | Genes in the cancer module 146. | 5.91e-04 | 102 | 41 | 4 | MODULE_146 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.91e-04 | 50 | 41 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3 | |
| Drug | C1 11-32 | 2.86e-16 | 18 | 72 | 8 | CID000443077 | |
| Drug | C11131 | 2.86e-16 | 18 | 72 | 8 | CID000443076 | |
| Drug | estriol-16-glucuronide | 1.32e-15 | 21 | 72 | 8 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 3.16e-15 | 23 | 72 | 8 | CID000066651 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.72e-14 | 29 | 72 | 8 | CID000125641 | |
| Drug | AC1Q6OQG | 8.73e-14 | 33 | 72 | 8 | CID000009686 | |
| Drug | BP-3,6-quinol | 8.73e-14 | 33 | 72 | 8 | CID000119292 | |
| Drug | morphine hydrochloride | UGT1A4 UGT1A3 PRLHR UGT1A5 CFTR SCN9A UGT2B4 UGT2B7 UGT2B15 CCR7 UGT2B28 TNFRSF10B UGT2B11 EIF2AK3 RTP4 ADCY5 OPRD1 | 1.17e-13 | 481 | 72 | 17 | CID000004253 |
| Drug | AC1NOWCJ | 1.47e-13 | 35 | 72 | 8 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.47e-13 | 35 | 72 | 8 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.47e-13 | 35 | 72 | 8 | CID000115255 | |
| Drug | l-borneol | 2.40e-13 | 37 | 72 | 8 | CID000010049 | |
| Drug | harmol | 4.75e-13 | 40 | 72 | 8 | CID000068094 | |
| Drug | testosterone glucuronide | 5.89e-13 | 41 | 72 | 8 | CID000108192 | |
| Drug | androsterone glucuronide | 8.89e-13 | 43 | 72 | 8 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 8.89e-13 | 43 | 72 | 8 | CID000009191 | |
| Drug | MS-222 | 1.08e-12 | 44 | 72 | 8 | CID000011400 | |
| Drug | salicylamide | 2.28e-12 | 48 | 72 | 8 | CID000005147 | |
| Drug | AC1N8H7N | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 OPRD1 | 2.89e-12 | 78 | 72 | 9 | CID004318740 |
| Drug | AC1NQGK1 | 4.51e-12 | 52 | 72 | 8 | CID005195977 | |
| Drug | ranirestat | 5.74e-12 | 7 | 72 | 5 | ctd:C115070 | |
| Drug | menthol | UGT1A4 UGT1A3 ADGRG2 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 7.94e-12 | 87 | 72 | 9 | CID000001254 |
| Drug | R(-)-Denopamine | 9.38e-12 | 33 | 72 | 7 | CID000003818 | |
| Drug | phenolphthalein | 1.13e-11 | 58 | 72 | 8 | CID000004764 | |
| Drug | urochloralic acid | 1.31e-11 | 59 | 72 | 8 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 1.31e-11 | 59 | 72 | 8 | CID000007103 | |
| Drug | 4-hydroxyestrone | 1.31e-11 | 59 | 72 | 8 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.31e-11 | 59 | 72 | 8 | CID000083944 | |
| Drug | SN-38G | 1.31e-11 | 59 | 72 | 8 | CID000443154 | |
| Drug | UDP-alpha-d-xylopyranose | 1.50e-11 | 60 | 72 | 8 | CID000001165 | |
| Drug | DCNB | UGT1A4 UGT1A3 UGT1A5 SCN9A UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 1.78e-11 | 95 | 72 | 9 | CID000007443 |
| Drug | DNCB | UGT1A4 UGT1A3 GPX8 UGT1A5 SCN9A UGT2B4 UGT2B7 UGT2B15 CCR7 UGT2B28 UGT2B11 | 1.87e-11 | 189 | 72 | 11 | CID000000006 |
| Drug | 3-OHBaP | 2.26e-11 | 63 | 72 | 8 | CID000025890 | |
| Drug | AC1L1OBF | 3.02e-11 | 20 | 72 | 6 | CID000032736 | |
| Drug | Meldola | 4.26e-11 | 68 | 72 | 8 | CID000081507 | |
| Drug | 2,2,2-trichloroethanol | 7.64e-11 | 73 | 72 | 8 | CID000008259 | |
| Drug | eugenol | 7.64e-11 | 73 | 72 | 8 | CID000003314 | |
| Drug | 7-hydroxycoumarin | 9.55e-11 | 75 | 72 | 8 | CID005281426 | |
| Drug | AS-3201 | 1.04e-10 | 24 | 72 | 6 | CID000153948 | |
| Drug | lithocholic acid | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 KCNMB4 UGT2B28 UGT2B11 | 1.10e-10 | 116 | 72 | 9 | CID000009903 |
| Drug | 16-epiestriol | 1.18e-10 | 77 | 72 | 8 | CID000003269 | |
| Drug | 4-nitrophenyl)imidazole | 1.25e-10 | 11 | 72 | 5 | CID000123155 | |
| Drug | alpha-naphthoflavone | UGT1A4 UGT1A3 UGT1A5 CFTR UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 1.28e-10 | 118 | 72 | 9 | CID000011790 |
| Drug | benzyloxyresorufin | 1.32e-10 | 78 | 72 | 8 | CID000114982 | |
| Drug | glucosiduronate | UGT1A4 UGT1A3 GLCE UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 CLEC2B | 1.57e-10 | 171 | 72 | 10 | CID000000610 |
| Drug | acridine | 1.79e-10 | 81 | 72 | 8 | CID000009215 | |
| Drug | 5 alpha-androstane | 2.41e-10 | 84 | 72 | 8 | CID000094144 | |
| Drug | 7-ethoxycoumarin | 2.92e-10 | 86 | 72 | 8 | CID000035703 | |
| Drug | pentoxyresorufin | 3.21e-10 | 87 | 72 | 8 | CID000107683 | |
| Drug | cotinine-N-glucuronide | 3.46e-10 | 13 | 72 | 5 | CID000000411 | |
| Drug | trans-3'-hydroxycotinine | 3.63e-10 | 29 | 72 | 6 | CID000000414 | |
| Drug | uridine 5'-diphosphoglucuronic acid | UGT1A4 UGT1A3 GPX8 UGT1A5 CFTR UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 4.20e-10 | 189 | 72 | 10 | CID000000390 |
| Drug | tolcapone | 4.52e-10 | 30 | 72 | 6 | CID004659569 | |
| Drug | AC1L7AJI | UGT1A4 UGT1A3 PCDHGA11 PCDHGA10 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 TNFRSF10B UGT2B11 | 4.83e-10 | 256 | 72 | 11 | CID000003750 |
| Drug | 4-aminobiphenyl | 5.05e-10 | 92 | 72 | 8 | CID000007102 | |
| Drug | p-nitroanisole | 5.05e-10 | 92 | 72 | 8 | CID000007485 | |
| Drug | propranolol glucuronide | 5.38e-10 | 14 | 72 | 5 | CID000119515 | |
| Drug | 2-naphthol | 5.51e-10 | 93 | 72 | 8 | CID000008663 | |
| Drug | ethoxyresorufin | 6.54e-10 | 95 | 72 | 8 | CID000003294 | |
| Drug | NNAL | 6.86e-10 | 32 | 72 | 6 | CID000104856 | |
| Drug | butylated hydroxytoluene | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 LPAR1 | 7.18e-10 | 143 | 72 | 9 | CID000031404 |
| Drug | DB04103 | 7.74e-10 | 97 | 72 | 8 | CID004469987 | |
| Drug | 1-naphthol | 8.41e-10 | 98 | 72 | 8 | CID000007005 | |
| Drug | 3-hydroxyandrostan-17-one | 1.16e-09 | 102 | 72 | 8 | CID000000225 | |
| Drug | 1'-hydroxyestragole | 1.17e-09 | 16 | 72 | 5 | CID000040003 | |
| Drug | chrysin | 1.58e-09 | 106 | 72 | 8 | CID005281607 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.65e-09 | 17 | 72 | 5 | CID000003573 | |
| Drug | fluconazole | 1.70e-09 | 107 | 72 | 8 | CID000003365 | |
| Drug | disulfiram | UGT1A4 UGT1A3 UGT1A5 CFTR UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 1.74e-09 | 158 | 72 | 9 | CID000003117 |
| Drug | AC1MRGT8 | 1.75e-09 | 67 | 72 | 7 | CID003517815 | |
| Drug | AC1LCF1F | UGT1A4 UGT1A3 UGT1A5 NPC1L1 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 2.05e-09 | 161 | 72 | 9 | CID000627275 |
| Drug | 2-naphthylamine | 2.12e-09 | 110 | 72 | 8 | CID000007057 | |
| Drug | al-Badry | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 LRRC4 | 2.55e-09 | 165 | 72 | 9 | CID000004545 |
| Drug | T4-G | 3.08e-09 | 19 | 72 | 5 | CID000152424 | |
| Drug | ethoxyquin | 3.24e-09 | 116 | 72 | 8 | CID000003293 | |
| Drug | buprenorphine hydrochloride solution | 3.33e-09 | 41 | 72 | 6 | CID000002476 | |
| Drug | AC1Q7AUJ | 3.47e-09 | 117 | 72 | 8 | CID000003303 | |
| Drug | 2-methoxyestradiol | UGT1A4 UGT1A3 UGT1A5 CFTR UGT2B4 UGT2B7 UGT2B15 UGT2B28 TNFRSF10B UGT2B11 | 3.62e-09 | 236 | 72 | 10 | CID000001573 |
| Drug | fibrates | 3.72e-09 | 118 | 72 | 8 | CID000002797 | |
| Drug | PTBP | 3.88e-09 | 42 | 72 | 6 | CID000007393 | |
| Drug | AC1NFJIQ | 3.88e-09 | 42 | 72 | 6 | CID004659568 | |
| Drug | benzphetamine | 3.97e-09 | 119 | 72 | 8 | CID000002341 | |
| Drug | N-hydroxy-PhIP | 4.49e-09 | 43 | 72 | 6 | CID000104954 | |
| Drug | 4-nitrophenol | UGT1A4 UGT1A3 UGT1A5 UGT2B4 UGT2B7 UGT2B15 KCNMB4 UGT2B28 UGT2B11 | 4.73e-09 | 177 | 72 | 9 | CID000000980 |
| Drug | 8-azaguanine | 5.18e-09 | 78 | 72 | 7 | CID000008646 | |
| Drug | hexobarbital | 6.66e-09 | 127 | 72 | 8 | CID000003608 | |
| Drug | AC1L1FK5 | 7.53e-09 | 129 | 72 | 8 | CID000003272 | |
| Drug | propofol | UGT1A4 UGT1A3 UGT1A5 SCN7A SCN9A UGT2B4 UGT2B7 UGT2B15 IL1R1 | 9.19e-09 | 191 | 72 | 9 | CID000004943 |
| Drug | scopoletin | 1.15e-08 | 50 | 72 | 6 | CID005280460 | |
| Drug | oltipraz | 1.21e-08 | 137 | 72 | 8 | CID000047318 | |
| Drug | Hymecromone | 1.39e-08 | 25 | 72 | 5 | ctd:D006923 | |
| Drug | N-acetylbenzidine | 1.39e-08 | 25 | 72 | 5 | CID000018787 | |
| Drug | UDP-N-acetylglucosamine | UGT1A4 UGT1A3 UGT1A5 FURIN UGT2B4 UGT2B7 UGT2B15 UGT2B28 UGT2B11 | 1.56e-08 | 203 | 72 | 9 | CID000001167 |
| Drug | aniline | 1.60e-08 | 142 | 72 | 8 | CID000006115 | |
| Drug | 2 E1 | 1.89e-08 | 145 | 72 | 8 | CID006102788 | |
| Drug | licochalcone A | 2.10e-08 | 27 | 72 | 5 | ctd:C070840 | |
| Drug | diflunisal | 2.10e-08 | 27 | 72 | 5 | CID000003059 | |
| Drug | L-idaro-1,4-lactone | 2.55e-08 | 28 | 72 | 5 | CID000078997 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 3.07e-08 | 29 | 72 | 5 | CID005375667 | |
| Drug | AC1L9E0Q | 3.68e-08 | 30 | 72 | 5 | CID000443095 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 3.84e-09 | 9 | 71 | 4 | EFO_0600040 | |
| Disease | X-19141 measurement | 2.16e-08 | 13 | 71 | 4 | EFO_0800799 | |
| Disease | X-24947 measurement | 2.18e-07 | 22 | 71 | 4 | EFO_0800910 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.41e-07 | 8 | 71 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.11e-06 | 9 | 71 | 3 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.11e-06 | 9 | 71 | 3 | EFO_0020691 | |
| Disease | X-21448 measurement | 1.58e-06 | 10 | 71 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.58e-06 | 10 | 71 | 3 | EFO_0802185 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.58e-06 | 10 | 71 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | X-23974 measurement | 1.58e-06 | 10 | 71 | 3 | EFO_0800867 | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.58e-06 | 10 | 71 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | bilirubin measurement, response to tenofovir | 1.58e-06 | 10 | 71 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | vitamin D deficiency | 1.91e-06 | 37 | 71 | 4 | EFO_0003762 | |
| Disease | X-21796 measurement | 2.17e-06 | 11 | 71 | 3 | EFO_0800825 | |
| Disease | plasma N-desmethylclozapine measurement | 2.17e-06 | 11 | 71 | 3 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 2.17e-06 | 11 | 71 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 2.17e-06 | 11 | 71 | 3 | EFO_0800972 | |
| Disease | aldosterone measurement | 2.17e-06 | 11 | 71 | 3 | EFO_0010219 | |
| Disease | biliverdin measurement | 2.89e-06 | 12 | 71 | 3 | EFO_0021033 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.89e-06 | 12 | 71 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | p-cresol glucuronide measurement | 2.89e-06 | 12 | 71 | 3 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 3.75e-06 | 13 | 71 | 3 | EFO_0802007 | |
| Disease | Congenital bilateral aplasia of vas deferens | 5.71e-06 | 2 | 71 | 2 | C0403814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 8.86e-06 | 17 | 71 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | phosphatidylcholine 36:4 measurement | 1.06e-05 | 18 | 71 | 3 | EFO_0010382 | |
| Disease | angiopoietin-related protein 1 measurement | 1.06e-05 | 18 | 71 | 3 | EFO_0801382 | |
| Disease | urate measurement, spine bone mineral density | 1.18e-05 | 58 | 71 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | disease progression measurement | 1.45e-05 | 61 | 71 | 4 | EFO_0008336 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.71e-05 | 3 | 71 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 1.71e-05 | 3 | 71 | 2 | C0014805 | |
| Disease | tissue factor measurement | 1.72e-05 | 21 | 71 | 3 | EFO_0010623 | |
| Disease | xanthurenate measurement | 4.66e-05 | 29 | 71 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 5.17e-05 | 30 | 71 | 3 | EFO_0600017 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.19e-04 | 7 | 71 | 2 | C0020075 | |
| Disease | X-24418 measurement | 1.19e-04 | 7 | 71 | 2 | EFO_0800879 | |
| Disease | Congenital Pain Insensitivity | 1.19e-04 | 7 | 71 | 2 | C0002768 | |
| Disease | vanillylmandelate (VMA) measurement | 1.19e-04 | 7 | 71 | 2 | EFO_0800119 | |
| Disease | cerebrovascular disease (is_implicated_in) | 1.58e-04 | 8 | 71 | 2 | DOID:6713 (is_implicated_in) | |
| Disease | deoxycholic acid glucuronide measurement | 1.58e-04 | 8 | 71 | 2 | EFO_0800575 | |
| Disease | serum N-desmethylclozapine measurement | 1.58e-04 | 8 | 71 | 2 | EFO_0600043 | |
| Disease | X-12844 measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0021339 | |
| Disease | vitamin D measurement, COVID-19 | 2.27e-04 | 49 | 71 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | pregnenetriol sulfate measurement | 3.10e-04 | 11 | 71 | 2 | EFO_0800586 | |
| Disease | Drugs used in diabetes use measurement | 3.79e-04 | 255 | 71 | 5 | EFO_0009924 | |
| Disease | metabolite measurement | 3.98e-04 | 560 | 71 | 7 | EFO_0004725 | |
| Disease | pregnenetriol disulfate measurement | 4.38e-04 | 13 | 71 | 2 | EFO_0800587 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.68e-04 | 157 | 71 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.54e-04 | 163 | 71 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | lymphocyte count | SLC4A7 ZNRF3 PCDHGA11 PCDHGA10 TBC1D7 S1PR2 CCR7 MEAK7 S1PR1 LPAR1 ADCY5 | 7.13e-04 | 1464 | 71 | 11 | EFO_0004587 |
| Disease | alkaline phosphatase measurement | TMEM176B ZNRF3 SIGLEC9 UGT2B4 UGT2B7 UGT2B15 S1PR2 UGT2B11 ADCY5 | 7.16e-04 | 1015 | 71 | 9 | EFO_0004533 |
| Disease | X-21441 measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0800814 | |
| Disease | cardiovascular disease | 8.18e-04 | 457 | 71 | 6 | EFO_0000319 | |
| Disease | testosterone measurement | UGT1A4 TMEM176B UGT1A5 UGT2B4 UGT2B7 UGT2B15 TNFRSF10B UGT2B11 ATP2B2 S1PR1 | 9.19e-04 | 1275 | 71 | 10 | EFO_0004908 |
| Disease | androsterone glucuronide measurement | 1.05e-03 | 20 | 71 | 2 | EFO_0800317 | |
| Disease | thyroxine measurement | 1.07e-03 | 83 | 71 | 3 | EFO_0005130 | |
| Disease | hormone measurement | 1.11e-03 | 84 | 71 | 3 | EFO_0004730 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.13e-03 | 189 | 71 | 4 | EFO_0009932 | |
| Disease | cholelithiasis | 1.27e-03 | 88 | 71 | 3 | EFO_0004799 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.27e-03 | 195 | 71 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | vitamin D measurement | 1.31e-03 | 336 | 71 | 5 | EFO_0004631 | |
| Disease | hemoglobin A1 measurement | 1.58e-03 | 520 | 71 | 6 | EFO_0007629 | |
| Disease | gallstones | 2.27e-03 | 108 | 71 | 3 | EFO_0004210 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLAVVLTVAFITFKC | 496 | P35503 | |
| IILRKIFTTISFCIV | 331 | P13569 | |
| TCITVDRFIVVVKAT | 121 | O00574 | |
| VATILFCIIATTFIV | 526 | Q9NZJ5 | |
| FKIFLVIICLHVVLV | 21 | Q8IZP9 | |
| AIKVIIAVVVVFIVF | 261 | P32248 | |
| KTLIIICALFTLVTV | 11 | O94923 | |
| TLVVFVSVIYSCVKL | 801 | O95622 | |
| EVFIQVLIKLRVCFV | 121 | Q2TB18 | |
| VKFFIIGVTVLVVAV | 441 | Q01814 | |
| VAVAAVSCIFLVFVI | 696 | Q9Y5H2 | |
| VSCIFLVFVIVLLAL | 701 | Q9Y5H2 | |
| LVKTVVIILGAFVVC | 236 | Q9HBW0 | |
| FLIFVRVICIVVSKL | 321 | P43220 | |
| ILIAKASVFFIVCVL | 106 | Q7Z3F1 | |
| LLKTVVIVLGAFIIC | 256 | Q92633 | |
| VAAVSCVFLAFVIVL | 701 | Q9Y5H3 | |
| TKIIIGCFVAVTLLA | 526 | Q9HBW1 | |
| VAIFLSVVICKGFLI | 206 | Q6P9B6 | |
| VKVFIIIAVFFICFV | 236 | Q9H244 | |
| VVVFCSLKVVTALAQ | 186 | Q9HC97 | |
| TVTKICVFLFAFVVP | 211 | P41143 | |
| VVIFLSIFVIIVTCL | 231 | Q15256 | |
| VLIIILCSVFAVVTI | 286 | Q9UHC9 | |
| VSVLVVVISITIFCL | 221 | Q16322 | |
| SCAFIVLVFVTVFLV | 721 | P09958 | |
| IIKVINFYLVCTLTI | 346 | Q7Z388 | |
| FVVGVLIVVLTICAK | 181 | Q86W47 | |
| AKVFAVLLSIVLCTV | 16 | Q8TED1 | |
| TCQIFGFVVSVLKSV | 101 | Q99679 | |
| KLTSVVFILICCFII | 46 | P21453 | |
| LLKTVTIVLGVFIVC | 231 | O95136 | |
| FVLTIGVIICVFIIF | 221 | Q9HBV2 | |
| ICVTLTVIIVCSVFI | 341 | P14778 | |
| TVIIVCSVFIYKIFK | 346 | P14778 | |
| SLAVFVFVVIVVSAC | 196 | Q6UXV1 | |
| LTIIACFAVIVSAKR | 116 | Q5T6X4 | |
| NVVLDFCCFIVIIIT | 201 | Q8NHC5 | |
| KHSAIAVVVIFLVCF | 241 | Q9UNW8 | |
| FCVELCLKVIVSLTV | 426 | Q8WU17 | |
| FILLLVFIVVKCFTS | 231 | Q96DX8 | |
| FKVTFTLVVSGIECI | 16 | P59535 | |
| VVLILTVFVAFCLLV | 626 | Q8IW52 | |
| ILALVATIFFVCTVV | 326 | Q14242 | |
| KVHIFTVIQLTCLVL | 1081 | Q9Y6M7 | |
| TFCLLVVIVVVFAVC | 276 | P49683 | |
| NVVFIILFTGECVLK | 1551 | Q15858 | |
| TVIVAVFVLLAVCII | 46 | A0A1B0GW64 | |
| CDKVTEFFLLILVSV | 451 | Q7Z333 | |
| TALVFLSFCVIFVVV | 356 | Q9Y336 | |
| IFVLSVVTIIICFTC | 116 | Q8N114 | |
| KFEISFVIWCIVLVL | 376 | Q9Y2E8 | |
| SCKILVFVAVEILLT | 231 | Q9P0N9 | |
| IRALFLAVCVLKVIV | 206 | Q3YBM2 | |
| AAKTLAIVVGVFVLC | 346 | P25100 | |
| KKCFIIVGVLITTNI | 6 | Q92478 | |
| FITITSLEICIVVFF | 46 | Q8IZ96 | |
| IVFTVLVFTVTLKLA | 1001 | Q8NB49 | |
| LIVGCIEVVFVTKFL | 1151 | Q96RL7 | |
| VCSELVKLVFCVLVS | 56 | Q9BS91 | |
| VKLVFCVLVSFCVIK | 61 | Q9BS91 | |
| FLLACVATVIFIITK | 496 | P06133 | |
| VATVIFIITKCLFCV | 501 | P06133 | |
| LLAVVLTVAFITFKC | 496 | P35504 | |
| AAVVLIVAVFVCKSL | 221 | O14763 | |
| FLLACVATVIFIITK | 496 | O75310 | |
| VATVIFIITKFCLFC | 501 | O75310 | |
| KLLVSITVTFVLCFT | 226 | Q8IYL9 | |
| IFLAFFVVVSLVCLI | 221 | Q9ULT6 | |
| FVVVSLVCLILLVKI | 226 | Q9ULT6 | |
| VVVIVFCLSLIGKTR | 1006 | Q01118 | |
| LCVIVFILITVIGKL | 786 | Q9UI33 | |
| VVIFTLECLIKIFAL | 1406 | Q9UI33 | |
| CVATVIFIITKFCLF | 501 | P54855 | |
| FLLACVATVIFVVTK | 496 | Q9BY64 | |
| FLLVCVATVIFIVTK | 496 | P16662 | |
| KIVLFLSFITILISC | 66 | Q8N7C4 | |
| IFLLSSICIVVKAIH | 161 | Q8TC26 | |
| AVIVCLAISVVVALF | 386 | O95185 | |
| LLAVVLTVAFITFKC | 496 | P22310 |